Listen
In our conversation with Joseph, we chat a bit about some critical topics such as how psychedelics can allow us...
In our conversation, James goes into detail about Mindset’s new lead drug candidate MSP-1014, when the company expects to take...
In this wide ranging interview many topics are covered, starting with the philosophy and vision of Bright Minds. We discuss...
In today’s episode of the Psychedelic Spotlight Podcast, James Hallifax from the Psychedelic Investor YouTube Channel interviews Ian McDonald, CEO...
MindMed Releases Data on TWO Clinical Trials: A Closer Look Into MMED's Psilocybin and LSD studies. Mind Medicine (MindMed), (NASDAQ:...
In our conversation with Trevor, we have the opportunity to discuss some of the psychedelic-based treatments NeonMind is currently focused...
In our conversation with Matt, we tackle a variety of extremely important and highly-relevant subject matters such as how technology...
Top 10 Psychedelic stocks to own according to PSIL ETF (DO I AGREE?) What’s up Psychedelic Investors!?! Today we are...
